Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 27;13(8):1631.
doi: 10.3390/life13081631.

Accelerated Atherosclerosis and Cardiovascular Toxicity Induced by Radiotherapy in Breast Cancer

Affiliations
Review

Accelerated Atherosclerosis and Cardiovascular Toxicity Induced by Radiotherapy in Breast Cancer

Miruna Florina Stefan et al. Life (Basel). .

Abstract

The number of patients diagnosed with breast cancer and cardiovascular disease is continuously rising. Treatment options for breast cancer have greatly evolved, but radiotherapy (RT) still has a key role in it. Despite many advances in RT techniques, cardiotoxicity is one of the most important side effects. The new cardio-oncology guidelines recommend a baseline evaluation, risk stratification and follow-up of these patients. Cardiotoxicity induced by RT can be represented by almost all forms of cardiovascular disease, with atherosclerosis being the most frequent. An interdisciplinary team should manage these patients, in order to have maximum therapeutic effect and minimum cardiovascular toxicity. This review will summarize the current incidence, risk factors, mechanisms and follow-up of RT-induced cardiovascular toxicity.

Keywords: breast cancer; cancer; cardiovascular toxicity; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cardiovascular pathologies induced by radiation therapy for breast cancer (modified and adapted from [35]).

Similar articles

Cited by

References

    1. [(accessed on 17 May 2023)]. Available online: https://www.iarc.who.int/news-events/current-and-future-burden-of-breast...
    1. Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Eur. Heart J. 2022;43:4229–4361. doi: 10.1093/eurheartj/ehac244. - DOI - PubMed
    1. Jacob S., Camilleri J., Derreumaux S., Walker V., Lairez O., Lapeyre M., Bruguière E., Pathak A., Bernier M.-O., Laurier D., et al. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: A dosimetric evaluation based on individually-determined radiation dose (BACCARAT study) Radiat. Oncol. 2019;14:29. doi: 10.1186/s13014-019-1234-z. - DOI - PMC - PubMed
    1. Reed G.W., Masri A., Griffin B.P., Kapadia S.R., Ellis S.G., Desai M.Y. Long-term mortality in patients with radiation-associated coronary artery disease treated with percu-taneous coronary intervention. Circ. Cardiovasc. Interv. 2016;9:e003483. doi: 10.1161/CIRCINTERVENTIONS.115.003483. - DOI - PubMed
    1. Tuohinen S.S., Skyttä T., Poutanen T., Huhtala H., Virtanen V., Kellokumpu-Lehtinen P.-L., Raatikainen P. Radiotherapy-induced global and regional differences in early-stage left-sided versus right-sided breast cancer patients: Speckle tracking echocardiography study. Int. J. Cardiovasc. Imaging. 2017;33:463–472. doi: 10.1007/s10554-016-1021-y. - DOI - PubMed

LinkOut - more resources